AERI - Aerie Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5694.7M
Enterprise value 3563.97M
Trailing P/E N/A
Forward P/E 1-7.40
PEG ratio (5-yr expected) 10.07
Price/sales (ttm)11.64
Price/book (mrq)3.29
Enterprise value/revenue 39.45
Enterprise value/EBITDA 6-3.14

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 3-56.23%
S&P500 52-week change 39.83%
52-week high 336.93
52-week low 310.80
50-day moving average 314.99
200-day moving average 318.05

Share statistics

Avg vol (3-month) 31.02M
Avg vol (10-day) 31.2M
Shares outstanding 546.47M
Float 37.37M
% held by insiders 12.08%
% held by institutions 1131.45%
Shares short (14 May 2020) 49.81M
Short ratio (14 May 2020) 410.98
Short % of float (14 May 2020) 429.13%
Short % of shares outstanding (14 May 2020) 421.11%
Shares short (prior month 14 Apr 2020) 49.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Sep 2019


Profit margin 0.00%
Operating margin (ttm)-317.45%

Management effectiveness

Return on assets (ttm)-30.04%
Return on equity (ttm)-82.04%

Income statement

Revenue (ttm)59.69M
Revenue per share (ttm)1.32
Quarterly revenue growth (yoy)154.00%
Gross profit (ttm)42.29M
EBITDA -179.66M
Net income avi to common (ttm)-195.98M
Diluted EPS (ttm)-4.32
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)340.78M
Total cash per share (mrq)7.36
Total debt (mrq)201.59M
Total debt/equity (mrq)96.36
Current ratio (mrq)5.43
Book value per share (mrq)4.55

Cash flow statement

Operating cash flow (ttm)-154.82M
Levered free cash flow (ttm)-92.14M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more